Form 4: BeiGene Director Wang Xiaodong Reports Share Sales Under 10b5-1 Plan

Director Wang Xiaodong reports the sale of BeiGene American Depositary Shares (ADS) on April 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Wang Xiaodong, a director at BeiGene, Ltd., filed a Form 4 disclosing changes in beneficial ownership.
• On April 14, 2025, Wang Xiaodong sold 41,760 American Depositary Shares (ADS) at $6.50 and then sold 15 transactions of ADS at prices ranging from $237.561 to $249.4529.
• These sales were executed under a Rule 10b5-1 trading plan adopted on August 12, 2024.
• Following the reported transactions, Wang Xiaodong directly owns 5,082,165 ordinary shares.
• Wang Xiaodong also indirectly owns 1,025,063 ordinary shares through a family trust, 3,953,100 ordinary shares through Wang Investment LLC, and 50 ordinary shares through his spouse.
• Wang Xiaodong also owns 1,085,767 share options.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of share sales by a director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their trading activities.

Stakeholder Impact

• The share sales could have a minor impact on shareholders, depending on the overall market perception of insider selling.
• The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates

Keywords

Form 4, beneficial ownership, Wang Xiaodong, BeiGene, ADS, Rule 10b5-1, share sales, director